World-leading Australian scientists say a vaccine is ready for widespread use in the beginning of the year – and that is under a & # 39; incredibly ambitious & # 39; timeline
- Scientists at the University of Queensland to begin human vaccine trials in June
- If successful, the COVID-19 vaccine could be rolled out in September
- Team with groundbreaking technology that can more easily neutralize viruses
- Pre-clinical tests that create higher immunity than virus recovered in patients
- Project Director Professor Trent Munro said the timeline & # 39; is incredibly ambitious & # 39; used to be
- Here you can help people who are not affected by Covid-19
Australian scientists say a vaccine could be ready for production in September after tests on mice yield promising results – but not available for widespread use until early next year.
Scientists from & # 39; University of Queensland said that the fast timeline & # 39; was incredibly ambitious, but reflected overwhelming success in pre-clinical studies.
Project leader Trent Munro said the September target for mass production was a realistic possibility, but that there were far more obstacles that her drugs had to jump through before it became available to the Australian public.
Professor Munro said testing on humans could begin as early as July – but warned that the vaccine would not be available for widespread use until early 2021.
Australian researchers from the University of Queensland said their pioneering vaccine could be ready for production by September
Scientists could start the vaccine on humans after trialing the final results of pre-clinical trials in July
Project co-leader Keith Chappell said the vaccine already generated higher levels of immunity to the virus in mice than in recovered human COVID-19 patients.
It comes as around 100 groups of researchers worldwide are developing a vaccine to neutralize SARS-CoV2 – the new virus strain that does not cause the coronavirus.
In April, Prime Minister Scott Morrison said that only a vaccine would allow Australians to return to normal life permanently.
Until then, he urged Australians to buckle for restrictive social distance measures – a time period that he said could be as long as six months.
The UQ scientists are using them molecular clamping technology to develop a vaccine – a groundbreaking process that includes & # 39; spike & # 39; to stabilize proteins and to recognize and eliminate the coronavirus.
Queensland premier Annastacia Palaszczuk pictured with the program leader of the researchers Professor Trent Munro
The vaccine was developed with molecular clamping technology that stores the 'spike' protein in a mold
CORONAVIRUS CASES IN AUSTRALIA: 6.746
New South Wales: 3,016
Western Australia: 551
South Australia: 438
Australian Capital Territory: 106
Northern Territory: 28
TOTAL CASES: 6,746
& # 39; That's the goal we & # 39; ve been working on, but, yeah, I think it's a possibility if everything went to plan, & # 39; told Professor Munro at The Australian.
& # 39; That [vaccine] may not be fully tested, it may not be ready for distribution, so I'm not trying to give you caveats, I'm just trying to be realistic. But our goal was really to demonstrate production at scale in that kind of time frame. & # 39;
He said it could be the first half of 2021 at the earliest before the vaccine is ready for mass distribution.
The co-leader of the University's project Professor Paul Young said on Wednesday that the pre-clinical results of growing the virus in cell cultures also indicated that the development of the vaccine will make plans.
Professor Kanta Subbarao of the Doherty Institute, who works with UQ, tests the vaccine samples in the laboratory.
& # 39; This is a very important finding because similar immune responses with SARS vaccines in animal models have led to protection against infection, & # 39; said Prof Subbarao.
Dutch company Viroclinics Xplore is also working on fax tests and finalizing pre-clinical work in the Netherlands.
The latest deaths take Australia's death toll to 88, while 6,729 people are infected and at least 5,624 have been recovered
Researchers at Queensland University have used rapid response technology to develop a vaccine that took three weeks to produce.
The candidate for coronavirus vaccine in China is & # 39; effective and safe & # 39; on animals, studies claims
A potential coronavirus vaccine developed by Chinese researchers has been proven effective and safe after conducting clinical trials on animals, a study from China said.
A study group from the country published the study on Sunday after successful testing of a vaccine candidate on macaques and mice.
The medical report also indicated that the inactivated vaccine, known as PiCoVacc, can trigger an immune response in animals to protect them against & # 39; virus strain.
A potential coronavirus vaccine developed by Chinese researchers has been proven effective and safe after performing clinical trials on animals, a study has said. The image shows a microbiologist with a biological sample tube labeled as COVID-19
The new study comes as scientists around the world have been racing to find a cure for the deadly disease. Chinese researchers have launched human trials on three vaccine candidates.
According to the report, researchers have injected groups of mice and macaques with different doses of the potential vaccine.
The vaccine was proven safe and effective despite still infection improvement as negative effects were observed in & # 39; study.
The scientists also noted that the study provided extensive evidence for the clinical development of potential COVID-19 vaccines, but further vaccine experiments on animals are needed.
Yang Zhanqiu, a virologist at Wuhan University, told Chinese media that the results of & # 39; a study is convincing that macaques are closer to humans.
The university received an application from the Coalition for Innovations for Epidemic Preparedness to use its newly patented DNA-based molecular clamping technology to track the vaccine after the virus hit the coasts of Australia in January.
Dr Chappell and his team of 20 researchers have spent the last 15 months preparing for a & # 39; rapid response & # 39 ;.
The technology uses the DNA sequence of the coronavirus released by China to produce a protein that is the same as that on the surface of the actual virus.
That protein will be the essence of the vaccine, capable of generating immune system responses that protect people.